WikiPsiquiatria - Posts previos
Mostrando entradas con la etiqueta depressive. Mostrar todas las entradas
Mostrando entradas con la etiqueta depressive. Mostrar todas las entradas

Mouse with 'off switch' in key brain cell population developed; Research may increase understanding of SIDS, depressive disorders

ScienceDaily (July 30, 2011) — NIH-funded scientists have developed a strain of mice with a built-in off switch that can selectively shut down the animals' serotonin-producing cells, which make up a brain network controlling breathing, temperature regulation, and mood. The switch controls only the serotonin-producing cells, and does not affect any other cells in the animal's brains or bodies.

When the researchers powered down the animals' serotonin cells, the animals failed to sufficiently step up their breathing to compensate for an increase of carbon dioxide in the air, and their body temperatures dropped to match the surrounding temperature.

The finding has implications for understanding sudden infant death syndrome, or SIDS, which has been linked to low serotonin levels, and is thought to involve breathing abnormalities and problems with temperature control. The finding may also provide insight into depressive disorders, which also involve serotonin metabolism.

The study results appear in the current issue of the journal Science.

SIDS is the death of an infant before his or her first birthday that cannot be explained after a complete autopsy, an investigation of the scene and circumstances of the death, and a review of the medical history of the infant and of his or her family. According to the National Center for Health Statistics, SIDS is the third leading cause of infant death.

"The single most effective way to reduce the risk of SIDS is to always place infants on their backs for sleep," said Marian Willinger, Ph.D., special assistant for SIDS at the NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development, which provided major funding for the study. "This new animal model of the serotonin-producing system holds the promise of helping us to understand the biological processes contributing to SIDS, which is critical for the development of tests and interventions to prevent these deaths.'' Additional NIH support was provided by the National Institute of Mental Health, National Institute on Drug Abuse, and National Center for Research Resources.

To conduct the study, the researchers developed mice with a unique molecule, or receptor, on the surface of their serotonin-producing brain cells, or neurons. Typically, cells communicate via chemicals that bind to receptors on their surfaces, with the molecules binding to their receptors in much the same way a key fits into a lock.

The researchers added this special receptor to the animal's serotonin-producing neurons using a genetic manipulation technique they developed called intersectional genetics. The special receptor was developed by NIH-funded researcher Bryan Roth. The approach consists of manipulating the animals' genetic material so that it manufacturers an additional receptor on the surface of its neurons. In this case, the animals' serotonin-producing cells began making a receptor that is not found in nature. Rather than binding to a naturally occurring brain chemical, the receptor binds to a chemical compound manufactured in a laboratory, clozapine-N-oxide (CNO).

"CNO was identified for its ability to bind specifically to this foreign receptor that we placed into the serotonin cells, and because it does not react with other cells or tissues in the animal's body," Dr. Dymecki explained.

When CNO binds with the receptor, it deactivates only the serotonin cells, effectively switching off all communications in the serotonin network. CNO does not affect any other cells in the animals' brains or bodies.

"By selectively switching off the serotonin-producing cells, we can get a definite idea of what bodily functions the serotonin cells specifically control" she said.

The researchers exposed genetically normal mice and mice with the receptor for CNO to elevated levels of carbon dioxide. Carbon dioxide is the waste product given off when a breath is exhaled. If carbon dioxide builds up in the body, due to insufficient breathing, it can be toxic, leading to loss of consciousness and death. The response to high carbon dioxide accumulation is increased breathing and a faster breathing rate, which releases carbon dioxide through the lungs.

When the normal mice were exposed to carbon dioxide, they almost immediately began to breathe faster and more deeply. In contrast, after their serotonin-producing neurons were switched off, mice with the receptor to CNO had a smaller response to carbon dioxide and did not increase their breathing as much.

"This finding shows that the breathing response to carbon dioxide is regulated by serotonin neurons," Dr. Dymecki said.

The researchers next tested the ability of the CNO-responsive mice to regulate their body temperatures. When the room temperature was set at 74 degrees Fahrenheit, the body temperature of normal mice remained at about 98.6 degrees -- the normal temperature for mice. Normal mice can maintain a normal body temperature even when the room temperature is cool and below that of body temperature, Dr. Dymecki added. However, after their serotonin neurons were switched off with CNO, the body temperatures of the CNO mice soon plunged. Like reptiles faced with a sudden temperature drop, the body temperatures of the mice soon dropped to the 74 degree room temperature.

"Their body temperatures were equilibrating with the room temperature," Dr. Dymecki said. "Our finding affirms that temperature is regulated by the serotonergic system."

Dr. Dymecki explained that the researchers added the CNO receptor to all the animals' serotonergic neurons. In future studies, she and her colleagues plan to selectively add the receptor to subsets of serotonergic receptors, to better understand their functioning in health, and in disorders such as SIDS and depression.

The finding provides support for previous autopsy studies by NIH grantees implicating abnormalities in serotonin metabolism in the brainstem as playing a role in SIDS.

Researchers theorize that infants who die of SIDS may have been unable to respond to breathing challenges, such as low levels of oxygen or high levels of carbon dioxide. High levels of carbon dioxide may accumulate around the face of an infant sleeping face down, when the infant's exhaled breath accumulates in a pocket formed by bedding materials.

The ability to regulate body temperature is also thought to play a role in SIDS deaths. The NICHD's Back to Sleep campaign advises parents and caregivers to avoid letting infants overheat during sleep, to dress them in light sleep clothes, avoid blankets or coverings, and to keep the room at a temperature that is comfortable for an adult.

Other authors of the paper were Russell Ray and Rachael Brust, also of the Department of Genetics at Harvard Medical School; Andrea Corcoran and Eugene Nattie, Department of Physiology at Dartmouth Medical School, in Lebanon, N.H.; Jun Chul Kim, Department of Psychology, University of Toronto, Toronto, Ontario, Canada; and George B. Richerson, Department of Neurology, University of Iowa in Iowa City.

Story Source:

The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by NIH/National Institute of Child Health and Human Development.

Journal Reference:

R. S. Ray, A. E. Corcoran, R. D. Brust, J. C. Kim, G. B. Richerson, E. Nattie, S. M. Dymecki. Impaired Respiratory and Body Temperature Control Upon Acute Serotonergic Neuron Inhibition. Science, 2011; 333 (6042): 637 DOI: 10.1126/science.1205295

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.



View the original article here

New way to examine major depressive disorder in children

ScienceDaily (May 10, 2011) — A landmark study by scientists at Wayne State University published in the May 6, 2011, issue of Archives of General Psychiatry, has revealed a new way to distinguish children with major depressive disorder (MDD) from not only normal children, but also from children with obsessive compulsive disorder (OCD).

MDD is a common, debilitating disease prevalent in childhood and adolescence. Examination of cortical thickness in patients with MDD has not been widely studied, and WSU's team of researchers set out to determine if differences in cortical thickness might not only distinguish children with depression from healthy children who are not depressed but also from those with other psychiatric disorders such as OCD.

Using a new technique to measure cortical thickness of 24 MDD patients, 24 OCD patients and 30 healthy control patients, the research team led by David Rosenberg, M.D., the Miriam L. Hamburger Endowed Chair of Child Psychiatry and professor of psychiatry and behavioral neurosciences in the School of Medicine at Wayne State University, and Erin Fallucca, M.D., a psychiatry resident at Wayne State University and the Detroit Medical Center, observed cortical thinning in five regions of the brain and greater thickness in the bilateral temporal pole in MDD patients. In OCD patients, the only significantly different region from healthy control patients was a thinner left supramarginal gyrus.

"The findings from our study are very exciting," said Rosenberg. "By measuring cortical thickness, we were able to distinguish depressed children not only from healthy children without depression, but also from those with another psychiatric disorder, obsessive compulsive disorder."

The study also revealed that familial depressed patients, or children with at least one first-degree relative with depression, had distinct cortical thickness compared to children with no obvious family history of mood disorder.

"Depressed children with and without a family history of depression who met the same clinical criteria of depression and who appeared the same clinically, had completely different cortical thickness based on their family history of depression," said Rosenberg.

This study offers an exciting new way to identify more objective markers of psychiatric illness in children. "It may have potential treatment significance for one-third of depressed children who do not respond to any treatment, and also for many who only partially respond with continued functional impairment," said Rosenberg. "We have found a clue to guide us to look at subtypes of depression just as we would in other chronic medical illnesses like diabetes, such as insulin dependent and non-insulin dependent diabetes."

This study was supported in part by the Paul Strauss Endowment for the Integration of Computer Science and Psychiatry, the National Institute of Mental Health of the National Institutes of Health, the State of Michigan Joe F. Young Sr. Psychiatric Research and Training Program, the World Heritage Foundation, the Schutt Foundation, the United Way, the National Alliance for Research on Schizophrenia and Depression and the Mental Illness Research Association.

Story Source:

The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by Wayne State University.

Journal Reference:

E. Fallucca, F. P. MacMaster, J. Haddad, P. Easter, R. Dick, G. May, J. A. Stanley, C. Rix, D. R. Rosenberg. Distinguishing Between Major Depressive Disorder and Obsessive-Compulsive Disorder in Children by Measuring Regional Cortical Thickness. Archives of General Psychiatry, 2011; 68 (5): 527 DOI: 10.1001/archgenpsychiatry.2011.36

Note: If no author is given, the source is cited instead.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.



View the original article here

Medscape Psychiatry

Scientific American - Mind & Brain

Nature Reviews Neuroscience - Issue - nature.com science feeds

Nature Reviews Neuroscience - AOP - nature.com science feeds

Nature Neuroscience - Issue - nature.com science feeds

Nature Neuroscience - AOP - nature.com science feeds

Translational Psychiatry

Neuropsychopharmacology - AOP - nature.com science feeds

Neuropsychopharmacology - Issue - nature.com science feeds